Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

8.630 USD -0.180 (-2.04%)
Official Closing Price Updated: 7:01 PM EDT, Apr 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Inovio Pharma

< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today reported financial results for the fourth quarter and year ended December 31, 2016. 
From GlobeNewswire News Releases
Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2016 Financial Results on March 15, 2017
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it will host a conference call and live webcast to discuss its 2016 fourth quarter and year end financial results and provide a corporate... 
From GlobeNewswire News Releases
Inovio’s SynCon® WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universal Cancer Immunotherapy
SynCon WT1 and PSMA antigens join hTERT in INO-5401, Inovio’s cancer product planned for immuno-oncology combination study 
From GlobeNewswire News Releases
Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious Diseases
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that Dr. David B. Weiner, Inovio’s co-founder, presented positive clinical data on Inovio’s DNA-based vaccines against MERS (Middle East... 
From GlobeNewswire News Releases
Blog Coverage Inovio Inks Collaboration and License Deal with ApolloBio for Greater China
From ACCESSWIRE
Inovio and ApolloBio to Collaborate on Development and Commercialization of HPV Pre-cancer Immunotherapy VGX-3100 in Greater China
Inovio to receive up to $50 million in upfront and near term payments and equity investment 
From GlobeNewswire News Releases
Research Reports Coverage on Biotech Stocks -- Inovio Pharma, Intra-Cellular Therapies, PhaseRx, and Global Blood Therapeutics
From PR Newswire
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the Company will participate in the following upcoming investment conferences: 
From GlobeNewswire News Releases
PCG Advisory Group (PCG) Announces Clients Participating During the 9th Annual Biotech Showcase(TM) Event and the 35th Annual J.P. Morgan Healthcare Conference in San Francisco
From ACCESSWIRE
Inovio’s Zika Vaccine Generates Robust Immune Responses in First Human Study
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced its DNA-based Zika vaccine (GLS-5700) generated robust antigen-specific antibody responses in a first-in-man, multi-center phase I trial. In... 
From GlobeNewswire News Releases
How These Biotech Stocks are Faring? -- Inovio Pharma, 22nd Century, Omeros, and Cerulean Pharma
From PR Newswire
Inovio MERS Vaccine Development to be Expanded with Funding from International Vaccine Institute
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the International Vaccine Institute (IVI) will provide new funding and support to further advance GLS-5300, Inovio’s vaccine to prevent... 
From GlobeNewswire News Releases
Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar Institute to Develop DNA-based Monoclonal Antibodies Against Zika Virus
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has been awarded a $6.1 million sub-grant through The Wistar Institute to develop a DNA-based monoclonal antibody designed to provide a... 
From GlobeNewswire News Releases
Inovio’s Co-Founder and Chair of its Scientific Advisory Board Selected as a Top 20 Translational Researcher
Dr. David B. Weiner recognized for his innovative medical and scientific research, which has been the basis for over 100 patents 
From GlobeNewswire News Releases
Inovio Wins Deloitte’s “Fast 500” Growth Award
Developer of DNA-based Immunotherapies Recognized For its Ability to Attract Grants and Partnerships 
From GlobeNewswire News Releases
Biotech Stocks on Investors' Radar -- Inovio Pharma, Pacific Biosciences of California, BioCryst Pharma, and Sangamo Biosciences
From PR Newswire
Inovio’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tissue and Peripheral Blood in Patients with HPV-Associated Head and Neck Cancer
Four of five study subjects in treated group show progression free survival ranging from nine to 24 months to date in phase I/IIa clinical study 
From GlobeNewswire News Releases
Inovio Pharmaceuticals Zika Vaccine Protects Animals from Infection, Brain Damage and Death
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that Inovio and its collaborators have published results in Nature Partner Journals (npj) Vaccines demonstrating that its Zika DNA vaccine... 
From GlobeNewswire News Releases
Inovio Pharmaceuticals Reports 2016 Third Quarter Financial Results
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today reported financial results for the quarter ended September 30, 2016. The following financial results provide a year-over-year comparison of the third... 
From GlobeNewswire News Releases
InvestorsObserver releases covered-call reports for ACADIA Pharmaceuticals, Valero Energy, Kite Pharma, Inovio Pharmaceuticals and Fitbit
InvestorsObserver issues critical PriceWatch Alerts for ACAD, FIT, INO, KITE, and VLO. 
From PR Newswire
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the Company will participate at the following upcoming investment conferences: 
From GlobeNewswire News Releases
Inovio Pharmaceuticals to Report Third Quarter 2016 Financial Results November 9, 2016
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it will host a conference call and live webcast to discuss its 2016 third quarter financial results and provide a corporate update on... 
From GlobeNewswire News Releases
Inovio Announces FDA Request for Additional Information For Phase III Program; Trial Initiation Delayed
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on its proposed phase III clinical program for VGX-3100. A clinical... 
From GlobeNewswire News Releases
InvestorsObserver releases covered-call reports for Inovio Pharmaceuticals, Varian Medical Systems, Heron Therapeutics, Chipotle Mexican Grill and Wynn Resorts
InvestorsObserver issues critical PriceWatch Alerts for CMG, HRTX, INO, VAR, and WYNN. 
From PR Newswire
Inovio CEO Selected As 2016 Healthcare Innovator
Inovio Pharmaceuticals, Inc. (NASDAQ:INO), today announced that its President and Chief Executive Officer, Dr. J. Joseph Kim, has been selected as a 2016 Healthcare Innovator by a panel of scientific... 
From GlobeNewswire News Releases
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced strategic leadership appointments to support the advancement of its portfolio of DNA-based cancer immunotherapies and infectious disease... 
From GlobeNewswire News Releases
Learn how to target a 20% return on Tesla Motors, or get option-trade ideas on Intra-Cellular Therapies, Inovio Pharmaceuticals, Universal Display Corporation and Southwestern Energy Company or any st
InvestorsObserver issues critical PriceWatch Alerts for INO, ITCI, OLED, SWN, and TSLA. 
From PR Newswire
Inovio’s Zika Vaccine Selected As 2016 Technology Breakthrough
Popular Mechanics magazine calls Inovio’s Zika prevention a completely new form of vaccination that may be the fastest vaccine ever to come to market 
From GlobeNewswire News Releases
Inovio Pharmaceuticals to Present at Upcoming Investment Conferences
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that the Company will present a corporate overview at the following upcoming conferences: 
From GlobeNewswire News Releases
Technical Roundup on Biotech Stocks -- Keryx Biopharma, Inovio Pharma, Seattle Genetics, and Arrowhead Pharma
From PR Newswire
< Previous 1 2
...
19 20 21 22 23 24 25 26 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.